SELLAS Life Sciences Group (SLS) has entered an agreement with IMPACT-AML, a pan-European clinical network, to run a new study of its CDK9 inhibitor SLS009 in high-risk newly diagnosed acute myeloid ...
The study will aim to prove oil-based seaweed product has the potential to be more effective than existing solutions Dr. Mallory Honan, Symbrosia's product and animal science lead, spoke about the ...
VANCOUVER, BC / ACCESS Newswire / January 15, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce the launch of a contr ...
Atai Life Sciences announced positive results from Beckley Psytech's Phase 2a study of BPL-003, an adjunctive treatment for patients with treatment-resistant depression (TRD) who are already on ...
Caris Life Sciences® today announced the presentation of a study that found drugs targeting specific pathways may have potentially significant benefit in a select subset of patients with uterine ...
Anthropic is launching Claude for Life Sciences, a new model aimed at aiding scientific research. Through integrations with leading life sciences players, the platform will help researchers at every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results